US 7687625
Dipeptidyl peptidase inhibitors
granted A61PA61P15/08A61P15/10
Quick answer
US patent 7687625 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P15/08, A61P15/10, A61P17/00, A61P19/10